Cholesterol-Lowering Gene Therapy Shows Early Promise in First Human Trial

New research seems to show the potential of a CRISPR-based gene therapy meant to neuter certain forms of cardiovascular disease. In the world’s first human trial of the therapy, people given the highest doses experienced significant and long-lasting re…

FDA Approves a New Obesity Drug Poised to Dethrone Wegovy

There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The w…

Fake Ozempic Has Sent Several People to the Hospital, Health Agency Warns

Health officials in Austria are the latest to warn the public to stay away from sketchy sources of semaglutide, the active ingredient in popular weight loss drugs Wegovy and Ozempic, following recent reports of severe adverse effects linked to counterf…

Eli Lilly’s Obesity Drug Helped People Lose 25% of Their Weight in Latest Trial

New research suggests that Eli Lilly’s tirzepatide can boost existing efforts to lose weight. The company’s latest clinical trial found that people who dropped at least 5% of their weight before taking the drug went on to lose substantially more weight…